Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer, and their families and friends, an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online (through the Internet) or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy-and-paste the link below into software that allows podcast subscriptions, such as iTunes or Juice.
For a variety of podcasts designed for professionals in the field of oncology, see the ASCO Podcasts.
A recording of the May 18, 2011 teleconference for patient advocates on the news coming out of the 2011 ASCO Annual Meeting. It includes a discussion of research on HPV testing for cervical cancer, screening and a new treatment for ovarian cancer, PSA testing for prostate cancer, predicting the risk of nerve damage from chemotherapy, treatment for advanced cancers, and the effects of smoking for women with a high risk of breast cancer.
Nicholas Vogelzang, MD, discusses the research highlights from the 2011 Genitourinary Cancers Symposium in Orlando, Florida, including research on prostate cancer.
Morton Kahlenberg, MD, discusses the research highlights from the 2011 Gastrointestinal Cancers Symposium in San Francisco, California, including research on esophageal cancer, anal cancer, colorectal cancer, and gastrointestinal stromal tumor.